Nuvectis Pharma, Inc.·4

Jun 24, 5:14 PM ET

Mosseri Marlio Charles 4

4 · Nuvectis Pharma, Inc. · Filed Jun 24, 2025

Insider Transaction Report

Form 4
Period: 2025-06-20
Transactions
  • Purchase

    Common Stock

    2025-06-20$7.99/sh+5,603$44,7682,981,806 total(indirect: By Emerald Hill Ventures SARL SPF.)
Holdings
  • Common Stock

    109,321
Footnotes (1)
  • [F1]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.

Documents

1 file
  • 4
    tm2518659-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT